MRPS12
gene geneOn this page
Also known as RPS12RPSM12uS12m
Summary
MRPS12 (mitochondrial ribosomal protein S12, HGNC:10380) is a protein-coding gene on chromosome 19q13.2, encoding Small ribosomal subunit protein uS12m (O15235). It is a selective cancer dependency (DepMap: 67.6% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S12P family. The encoded protein is a key component of the ribosomal small subunit and controls the decoding fidelity and susceptibility to aminoglycoside antibiotics. The gene for mitochondrial seryl-tRNA synthetase is located upstream and adjacent to this gene, and both genes are possible candidates for the autosomal dominant deafness gene (DFNA4). Splice variants that differ in the 5’ UTR have been found for this gene; all three variants encode the same protein.
Source: NCBI Gene 6183 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 34 total
- Cancer dependency (DepMap): dependent in 67.6% of screened cell lines
- MANE Select transcript:
NM_033362
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10380 |
| Approved symbol | MRPS12 |
| Name | mitochondrial ribosomal protein S12 |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RPS12, RPSM12, uS12m |
| Ensembl gene | ENSG00000128626 |
| Ensembl biotype | protein_coding |
| OMIM | 603021 |
| Entrez | 6183 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 8 protein_coding, 1 retained_intron
ENST00000308018, ENST00000402029, ENST00000407800, ENST00000598734, ENST00000899577, ENST00000933522, ENST00000933523, ENST00000933524, ENST00000968236
RefSeq mRNA: 3 — MANE Select: NM_033362
NM_021107, NM_033362, NM_033363
CCDS: CCDS12525
Canonical transcript exons
ENST00000308018 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001199341 | 38931276 | 38931343 |
| ENSE00003038280 | 38930944 | 38930998 |
| ENSE00003906959 | 38932333 | 38933168 |
Expression profiles
Bgee: expression breadth ubiquitous, 139 present calls, max score 96.84.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 58.8697 / max 270.1536, expressed in 1817 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175676 | 58.8697 | 1817 |
Top tissues by expression
139 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 96.84 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 95.96 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.07 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.31 | gold quality |
| heart | UBERON:0000948 | 93.17 | gold quality |
| right lobe of liver | UBERON:0001114 | 92.83 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 92.60 | gold quality |
| right adrenal gland | UBERON:0001233 | 92.46 | gold quality |
| gastrocnemius | UBERON:0001388 | 92.35 | gold quality |
| left adrenal gland | UBERON:0001234 | 92.17 | gold quality |
| body of stomach | UBERON:0001161 | 92.14 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 92.14 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 92.11 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 92.02 | gold quality |
| esophagus mucosa | UBERON:0002469 | 91.89 | gold quality |
| metanephros cortex | UBERON:0010533 | 91.70 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 91.59 | gold quality |
| muscle of leg | UBERON:0001383 | 91.42 | gold quality |
| cortex of kidney | UBERON:0001225 | 91.20 | gold quality |
| transverse colon | UBERON:0001157 | 90.97 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.92 | gold quality |
| granulocyte | CL:0000094 | 90.48 | gold quality |
| fundus of stomach | UBERON:0001160 | 90.33 | gold quality |
| adrenal gland | UBERON:0002369 | 90.26 | gold quality |
| esophagus | UBERON:0001043 | 90.08 | gold quality |
| prefrontal cortex | UBERON:0000451 | 89.89 | gold quality |
| skin of leg | UBERON:0001511 | 89.45 | gold quality |
| spleen | UBERON:0002106 | 89.39 | gold quality |
| body of pancreas | UBERON:0001150 | 89.33 | gold quality |
| skin of abdomen | UBERON:0001416 | 89.31 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.01 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting MRPS12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6753-3P | 99.93 | 66.57 | 637 |
| HSA-MIR-7107-3P | 99.93 | 66.73 | 627 |
| HSA-MIR-135A-5P | 99.36 | 71.85 | 1601 |
| HSA-MIR-135B-5P | 99.36 | 71.63 | 1613 |
| HSA-MIR-499A-3P | 99.18 | 69.20 | 1392 |
| HSA-MIR-499B-3P | 99.18 | 69.27 | 1391 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-203B-5P | 97.24 | 68.54 | 543 |
| HSA-MIR-6718-5P | 97.24 | 68.15 | 553 |
| HSA-MIR-505-5P | 97.01 | 65.54 | 778 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 67.6% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 4)
- Homo sapiens mitochondrial ribosomal protein S12 (PMID:12706105)
- mitochondrial ribosomal protein S12 3’-UTR interacts specifically with TRAP1 (tumor necrosis factor receptor-associated protein1), hnRNPM4 (heterogeneous nuclear ribonucleoprotein M4), Hsp70 and Hsp60 (heat shock proteins 70 and 60), and alpha-tubulin (PMID:18790094)
- NF-Y type CCAAT boxes are found preferentially in bidirectional Mrps12/Sarsm promoters, but many such promoters lack them and must be regulated in another way. (PMID:19439209)
- A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate. (PMID:33663122)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrps12 | ENSDARG00000089836 |
| mus_musculus | Mrps12 | ENSMUSG00000045948 |
| rattus_norvegicus | Mrps12 | ENSRNOG00000019949 |
| drosophila_melanogaster | tko | FBGN0003714 |
| caenorhabditis_elegans | WBGENE00011391 |
Paralogs (1): RPS23 (ENSG00000186468)
Protein
Protein identifiers
Small ribosomal subunit protein uS12m — O15235 (reviewed: O15235)
Alternative names: 28S ribosomal protein S12, mitochondrial, MT-RPS12
All UniProt accessions (1): O15235
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the universal ribosomal protein uS12 family.
RefSeq proteins (3): NP_066930, NP_203526, NP_203527 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005679 | Ribosomal_uS12_bact | Family |
| IPR006032 | Ribosomal_uS12 | Family |
| IPR012340 | NA-bd_OB-fold | Homologous_superfamily |
Pfam: PF00164
UniProt features (12 total): strand 6, transit peptide 1, chain 1, region of interest 1, sequence variant 1, helix 1, turn 1
Structure
Experimental structures (PDB)
77 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 9OJM | ELECTRON MICROSCOPY | 2.5 |
| 8CSQ | ELECTRON MICROSCOPY | 2.54 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 8CSP | ELECTRON MICROSCOPY | 2.66 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O15235-F1 | 86.81 | 0.78 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 386 (showing top):
GOBP_CYTOPLASMIC_TRANSLATION, ELVIDGE_HYPOXIA_DN, GOBP_RIBOSOME_BIOGENESIS, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, BASSO_B_LYMPHOCYTE_NETWORK, GNF2_TPT1, ENK_UV_RESPONSE_KERATINOCYTE_UP, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, MORF_UBE2I, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, MORF_HDAC1, GOBP_MITOCHONDRIAL_TRANSLATION, DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, LINDGREN_BLADDER_CANCER_CLUSTER_3_DN, GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (7): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial ribosome (GO:0005761), mitochondrial small ribosomal subunit (GO:0005763), ribosome (GO:0005840), small ribosomal subunit (GO:0015935), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar ribosome | 1 |
| mitochondrial matrix | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| ribosomal subunit | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
4400 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS12 | MYH14 | Q7Z406 | 939 |
| MRPS12 | BAX | P55269 | 763 |
| MRPS12 | MRPL32 | Q9BYC8 | 625 |
| MRPS12 | MRPS11 | P82912 | 617 |
| MRPS12 | MRPL12 | P52815 | 616 |
| MRPS12 | MRPL17 | Q9NRX2 | 607 |
| MRPS12 | DMPK | Q09013 | 586 |
| MRPS12 | GJB2 | P29033 | 582 |
| MRPS12 | MRPL2 | Q5T653 | 565 |
| MRPS12 | IMP4 | Q96G21 | 544 |
| MRPS12 | RPS12 | P25398 | 536 |
| MRPS12 | TUFM | P49411 | 508 |
| MRPS12 | MRPS15 | P82914 | 493 |
| MRPS12 | MRPS16 | Q9Y3D3 | 490 |
| MRPS12 | MT-CO1 | P00395 | 458 |
IntAct
84 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FBL | NOP56 | psi-mi:“MI:0914”(association) | 0.800 |
| CNOT2 | CNOT1 | psi-mi:“MI:0914”(association) | 0.740 |
| TEFM | POLRMT | psi-mi:“MI:0914”(association) | 0.560 |
| MRPS12 | SPINK7 | psi-mi:“MI:0915”(physical association) | 0.550 |
| SPINK7 | MRPS12 | psi-mi:“MI:0915”(physical association) | 0.550 |
| DKK3 | NME4 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS12 | MTIF2 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | MRPS12 | psi-mi:“MI:0914”(association) | 0.530 |
| NOTCH2 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNRD2 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| TGOLN2 | PGRMC1 | psi-mi:“MI:0914”(association) | 0.420 |
| FER1L5 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| Cdc23 | ANAPC15 | psi-mi:“MI:0914”(association) | 0.350 |
| CKAP5 | TACC3 | psi-mi:“MI:0914”(association) | 0.350 |
| Kif2c | MRPS12 | psi-mi:“MI:0914”(association) | 0.350 |
| ZSCAN5A | MRPS12 | psi-mi:“MI:0914”(association) | 0.350 |
| USP43 | DKFZP586J0619 | psi-mi:“MI:0914”(association) | 0.350 |
| MPHOSPH8 | HCFC1 | psi-mi:“MI:0914”(association) | 0.350 |
| Nfyc | BDP1 | psi-mi:“MI:0914”(association) | 0.350 |
| Dctn1 | DERL1 | psi-mi:“MI:0914”(association) | 0.350 |
| E7 | COPE | psi-mi:“MI:0914”(association) | 0.350 |
| CDK7 | SEC16A | psi-mi:“MI:0914”(association) | 0.350 |
| EEA1 | SEC16A | psi-mi:“MI:0914”(association) | 0.350 |
| MAD2L2 | psi-mi:“MI:0914”(association) | 0.350 | |
| SMARCB1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (263): MRPS12 (Co-fractionation), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Affinity Capture-MS), MRPS12 (Two-hybrid), MRPS12 (Proximity Label-MS), MRPS12 (Affinity Capture-MS)
ESM2 similar proteins: A0L5W8, A2C4U8, A2CC84, A2T357, A4GGC9, A4GYT5, A4SCQ4, A4TGY4, A9ETB7, B0SUQ4, B2RLZ6, B3EH96, B3QR56, B4R8L1, B4S5N2, B4SBU2, B6EPR5, B7VLG2, C1DKK7, O14182, O15235, O35680, P07134, P10735, P53732, Q056Z9, Q0BYA9, Q0G9J5, Q14FB1, Q15YA9, Q1ACP3, Q1KXY0, Q1LSY7, Q20EW0, Q29RU1, Q32RQ9, Q332V3, Q3APG8, Q46IW1, Q49KX4
Diamond homologs: A0A1D8PDU3, A0B562, A0RUR2, A1E9Q2, A1E9Y6, A1RSE4, A1RWW1, A2BN38, A2STX1, A3CXN0, A3DMP8, A3MXZ4, A4FWF2, A4WNA3, A5ULM8, A6UV46, A6VGV3, A7I4X6, A8A929, B0R8D1, G1SZ47, O15235, O27129, O28387, O35680, O59229, P06147, P0C460, P0C461, P0CT75, P0CT76, P0CX00, P0CX29, P0CX30, P0CY39, P0CY40, P10735, P11524, P12149, P12340
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS12 | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 103 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation initiation | 8 | 16.1× | 1e-05 |
| Mitochondrial translation | 7 | 15.3× | 6e-05 |
| Mitochondrial translation elongation | 7 | 14.1× | 7e-05 |
| Mitochondrial ribosome-associated quality control | 7 | 13.6× | 7e-05 |
| Mitochondrial translation termination | 7 | 12.2× | 1e-04 |
| ER to Golgi Anterograde Transport | 5 | 10.5× | 4e-03 |
| Recruitment of NuMA to mitotic centrosomes | 5 | 9.2× | 5e-03 |
| EML4 and NUDC in mitotic spindle formation | 6 | 8.8× | 4e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 7 | 13.7× | 5e-04 |
| microtubule cytoskeleton organization | 7 | 9.5× | 3e-03 |
| cell division | 10 | 5.2× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
812 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:38931341:GTG:G | donor_gain | 1.0000 |
| 19:38932331:A:AG | acceptor_gain | 1.0000 |
| 19:38932332:G:GG | acceptor_gain | 1.0000 |
| 6:132814611:GGG:G | donor_gain | 1.0000 |
| 6:132814612:GG:G | donor_gain | 1.0000 |
| 6:132814612:GGG:G | donor_gain | 1.0000 |
| 6:132814613:GG:G | donor_gain | 1.0000 |
| 6:132814614:G:GG | donor_gain | 1.0000 |
| 6:132814614:GT:G | donor_loss | 1.0000 |
| 6:132814615:T:A | donor_loss | 1.0000 |
| 6:132814730:A:AG | acceptor_gain | 1.0000 |
| 6:132814731:G:GG | acceptor_gain | 1.0000 |
| 6:132814731:GT:G | acceptor_gain | 1.0000 |
| 6:132814731:GTGC:G | acceptor_gain | 1.0000 |
| 6:132814778:G:GT | donor_gain | 1.0000 |
| 6:132814779:A:T | donor_gain | 1.0000 |
| 6:132814781:GG:G | donor_gain | 1.0000 |
| 6:132814782:GG:G | donor_gain | 1.0000 |
| 6:132814970:A:G | acceptor_gain | 1.0000 |
| 6:132815014:A:G | acceptor_gain | 1.0000 |
| 6:132815089:G:GG | donor_gain | 1.0000 |
| 6:132816451:T:TA | acceptor_gain | 1.0000 |
| 6:132816455:TTTCA:T | acceptor_loss | 1.0000 |
| 6:132816457:TCA:T | acceptor_loss | 1.0000 |
| 6:132816459:A:AG | acceptor_gain | 1.0000 |
| 6:132816459:AG:A | acceptor_gain | 1.0000 |
| 6:132816459:AGGC:A | acceptor_gain | 1.0000 |
| 6:132816460:G:GT | acceptor_gain | 1.0000 |
| 6:132816460:GG:G | acceptor_gain | 1.0000 |
| 6:132816460:GGC:G | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000951164 (19:38932831 G>A), RS1001086937 (19:38933025 C>T), RS1002035764 (19:38933428 C>T), RS1002300430 (19:38929989 T>C), RS1002436163 (19:38929777 C>A,G,T), RS1002505771 (19:38932616 G>C), RS1002637535 (19:38931034 G>A,T), RS1004348213 (19:38929684 C>T), RS1004358856 (19:38929383 T>C), RS1004949966 (19:38933586 G>A,T), RS1005101081 (19:38930564 A>C,G,T), RS1005389149 (19:38933357 A>G), RS1005987074 (19:38932237 T>A), RS1006634693 (19:38933165 C>A,T), RS1007094761 (19:38932874 G>A)
Disease associations
OMIM: gene MIM:603021 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | affects cotreatment, decreases expression | 3 |
| Valproic Acid | affects cotreatment, increases expression | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-hydroxy-equilenin | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| K 7174 | decreases expression | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | increases response to substance, decreases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Bortezomib | decreases expression | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Calcitriol | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Enzyme Inhibitors | increases O-linked glycosylation, decreases activity | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydralazine | increases expression, affects cotreatment | 1 |
| Lead | increases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Tunicamycin | decreases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Asbestos, Crocidolite | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.